These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23715821)

  • 1. Treatment of seborrheic dermatitis: comparison of sertaconazole 2 % cream versus pimecrolimus 1 % cream.
    Goldust M; Rezaee E; Raghifar R
    Ir J Med Sci; 2013 Dec; 182(4):703-6. PubMed ID: 23715821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of seborrheic dermatitis: the efficiency of sertaconazole 2% cream vs. tacrolimus 0.03% cream.
    Goldust M; Rezaee E; Raghifar R; Hemayat S
    Ann Parasitol; 2013; 59(2):73-7. PubMed ID: 24171300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical study of sertaconazole 2% cream vs. hydrocortisone 1% cream in the treatment of seborrheic dermatitis.
    Goldust M; Rezaee E; Masoudnia S; Raghifar R
    Ann Parasitol; 2013; 59(3):119-23. PubMed ID: 24881281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of pimecrolimus 1% cream vs. sertaconazole 2% cream in the treatment of patients with facial seborrhoeic dermatitis: a randomized blinded trial.
    Azizzadeh M; Pahlevan D; Bagheri B
    Clin Exp Dermatol; 2022 May; 47(5):926-931. PubMed ID: 34910320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double blind study of sertaconazole 2% cream vs. clotrimazole 1% cream in treatment of seborrheic dermatitis.
    Goldust M; Rezaee E; Rouhani S
    Ann Parasitol; 2013; 59(1):25-9. PubMed ID: 23829055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double blind study of the effectiveness of sertaconazole 2% cream vs. metronidazole 1% gel in the treatment of seborrheic dermatitis.
    Goldust M; Rezaee E; Raghifar R
    Ann Parasitol; 2013; 59(4):173-7. PubMed ID: 24791343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different regimens of pimecrolimus 1% cream in the treatment of facial seborrheic dermatitis.
    Zhao J; Sun W; Zhang C; Wu J; Le Y; Huang C; Liu Y; Xiang L
    J Cosmet Dermatol; 2018 Feb; 17(1):90-94. PubMed ID: 28589618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study.
    Ozden MG; Tekin NS; Ilter N; Ankarali H
    Am J Clin Dermatol; 2010; 11(1):51-4. PubMed ID: 20000875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study.
    Cicek D; Kandi B; Bakar S; Turgut D
    J Dermatolog Treat; 2009; 20(6):344-9. PubMed ID: 19954391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
    Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
    Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pimecrolimus 1% cream for the treatment of seborrheic dermatitis: a systematic review of randomized controlled trials.
    Ang-Tiu CU; Meghrajani CF; Maano CC
    Expert Rev Clin Pharmacol; 2012 Jan; 5(1):91-7. PubMed ID: 22142161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis.
    Koc E; Arca E; Kose O; Akar A
    J Dermatolog Treat; 2009; 20(1):4-9. PubMed ID: 18677657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
    Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
    J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertaconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis.
    Goldust M; Ranjkesh MR; Amirinia M; Golforoushan F; Rezaee E; Rezazadeh Saatlou MA
    J Dermatolog Treat; 2013 Feb; ():. PubMed ID: 23210976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of facial seborrheic dermatitis with pimecrolimus cream 1%: an open-label clinical study in Korean patients.
    Kim BS; Kim SH; Kim MB; Oh CK; Jang HS; Kwon KS
    J Korean Med Sci; 2007 Oct; 22(5):868-72. PubMed ID: 17982237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of seborrheic dermatitis, comparison of sertaconazole 2% cream versus ketoconazole 2% cream.
    Lotti T; Goldust M; Rezaee E
    J Dermatolog Treat; 2013 May; ():. PubMed ID: 23441833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV.
    de Moraes AP; de Arruda EA; Vitoriano MA; de Moraes Filho MO; Bezerra FA; de Magalhães Holanda E; de Moraes ME
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):596-601. PubMed ID: 17447972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial.
    Firooz A; Solhpour A; Gorouhi F; Daneshpazhooh M; Balighi K; Farsinejad K; Rashighi-Firoozabadi M; Dowlati Y
    Arch Dermatol; 2006 Aug; 142(8):1066-7. PubMed ID: 16924062
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of sertaconazole 2% cream versus hydrocortisone 1% ointment in the treatment of atopic dermatitis.
    Saki N; Jowkar F; Alyaseen S
    J Dermatolog Treat; 2013 Dec; 24(6):447-9. PubMed ID: 23470235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pimecrolimus cream 1% can be an effective treatment for seborrheic dermatitis of the face and trunk.
    Rallis E; Nasiopoulou A; Kouskoukis C; Koumantaki E
    Drugs Exp Clin Res; 2004; 30(5-6):191-5. PubMed ID: 15700745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.